These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31536343)

  • 1. Tuning the Optical Properties of Novel Antitumoral Drugs Based on Cyclometalated Iridium(III) Complexes.
    Cerón-Carrasco JP; Zúñiga J; Requena A
    J Phys Chem A; 2019 Oct; 123(40):8644-8649. PubMed ID: 31536343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes.
    Liu B; Monro S; Lystrom L; Cameron CG; Colón K; Yin H; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2018 Aug; 57(16):9859-9872. PubMed ID: 30091916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Substituents on Excited-State and Photosensitizing Properties in Cationic Iridium(III) Complexes with Ligands of Coumarin 6.
    Takizawa SY; Ikuta N; Zeng F; Komaru S; Sebata S; Murata S
    Inorg Chem; 2016 Sep; 55(17):8723-35. PubMed ID: 27548036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
    Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and photochemical properties of pH responsive tris-cyclometalated iridium(III) complexes that contain a pyridine ring on the 2-phenylpyridine ligand.
    Nakagawa A; Hisamatsu Y; Moromizato S; Kohno M; Aoki S
    Inorg Chem; 2014 Jan; 53(1):409-22. PubMed ID: 24341415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclometalated Iridium(III) Complexes as High-Sensitivity Two-Photon Excited Mitochondria Dyes and Near-Infrared Photodynamic Therapy Agents.
    Bi XD; Yang R; Zhou YC; Chen D; Li GK; Guo YX; Wang MF; Liu D; Gao F
    Inorg Chem; 2020 Oct; 59(20):14920-14931. PubMed ID: 32951429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling the excited state and photosensitizing property of a 2-(2-pyridyl)benzo[b]thiophene-based cationic iridium complex through simple chemical modification.
    Takizawa SY; Shimada K; Sato Y; Murata S
    Inorg Chem; 2014 Mar; 53(6):2983-95. PubMed ID: 24568295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-order NLO properties of bis-cyclometalated iridium(Ⅲ) complexes: Substituent effect and redox switch.
    Li X; Wang HQ; Ye JT; Zhang Y; Qiu YQ
    J Mol Graph Model; 2019 Jun; 89():131-138. PubMed ID: 30884450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated Ir
    Martínez-Alonso M; Busto N; Aguirre LD; Berlanga L; Carrión MC; Cuevas JV; Rodríguez AM; Carbayo A; Manzano BR; Ortí E; Jalón FA; García B; Espino G
    Chemistry; 2018 Nov; 24(66):17523-17537. PubMed ID: 30176086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DFT Simulation of Structural and Optical Properties of 9-Aminoacridine Half-Sandwich Ru(II), Rh(III), and Ir(III) Antitumoral Complexes and Their Interaction with DNA.
    Cerón-Carrasco JP; Ruiz J; Vicente C; de Haro C; Bautista D; Zúñiga J; Requena A
    J Chem Theory Comput; 2017 Aug; 13(8):3898-3910. PubMed ID: 28641006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AcetylacetonateBODIPY-Biscyclometalated Iridium(III) Complexes: Effective Strategy towards Smarter Fluorescent Photosensitizer Agents.
    Palao E; Sola-Llano R; Tabero A; Manzano H; Agarrabeitia AR; Villanueva A; López-Arbeloa I; Martínez-Martínez V; Ortiz MJ
    Chemistry; 2017 Jul; 23(42):10139-10147. PubMed ID: 28543812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient enhancement of the visible-light absorption of cyclometalated Ir(III) complexes triplet photosensitizers with Bodipy and applications in photooxidation and triplet-triplet annihilation upconversion.
    Sun J; Zhong F; Yi X; Zhao J
    Inorg Chem; 2013 Jun; 52(11):6299-310. PubMed ID: 23327589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical Properties of Red-Emitting Tris(cyclometalated) Iridium(III) Complexes Having Basic and Nitro Groups and Application to pH Sensing and Photoinduced Cell Death.
    Kando A; Hisamatsu Y; Ohwada H; Itoh T; Moromizato S; Kohno M; Aoki S
    Inorg Chem; 2015 Jun; 54(11):5342-57. PubMed ID: 25978770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir
    Novohradsky V; Rovira A; Hally C; Galindo A; Vigueras G; Gandioso A; Svitelova M; Bresolí-Obach R; Kostrhunova H; Markova L; Kasparkova J; Nonell S; Ruiz J; Brabec V; Marchán V
    Angew Chem Int Ed Engl; 2019 May; 58(19):6311-6315. PubMed ID: 30889300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
    Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
    Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-soluble cyclometalated Ir(III) complexes as carrier-free and pure nanoparticle photosensitizers for photodynamic therapy and cell imaging.
    Tong X; Zhang L; Li L; Li Y; Yang Z; Zhu D; Xie Z
    Dalton Trans; 2020 Aug; 49(33):11493-11497. PubMed ID: 32789382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.
    Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W
    Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
    Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW
    Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.